SIGN IN Manual and automated plasmid purification methods each have their distinct approaches. Manual purification is hands-on and time-consuming, requiring significant user involvement. Automated ...

Osun INEC seeks media partnership to boost voter registration and PVC collection ahead of the 2026 elections. Learn about online and physical registration details.

Elenagen™, a novel DNA plasmid therapy that previously demonstrated high clinical benefit and low toxicity in cancer patients, has now shown significant promise in alleviating chronic pain ...

The Viral Vectors and Plasmid DNA Manufacturing Market forecast indicates a surge past $6 billion by 2025, driven by gene therapy advancements. The report highlights market dynamics, growth ...

ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of ...

Contractors and other commercial purchasers of PVC pipe have secured their first settlement in a lawsuit in U.S. court accusing some of the industry’s largest manufacturers of conspiring to fix ...

Enhancing productivity with the Thermo Scientific™ KingFisher™ PlasmidPro Maxi Processor—a complete walk-away maxi-scale plasmid purification Introducing automated high-throughput Applied Biosystems™ ...

An electrical contractor has filed an antitrust lawsuit in U.S. court accusing Westlake, Atkore and other major PVC pipe manufacturers of conspiring to overcharge municipal and commercial buyers.

As strategic partners going forward, Oxford Nanopore and Plasmidsaurus will also co-develop new technologies, reagents, and applications beyond plasmid sequencing, including microbial and gene ...

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific™ KingFisher™ PlasmidPro Maxi Processor* (Pl ...

A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label phase 2 SCOPE trial.

Thermo Fisher is downsizing at the plasmid DNA manufacturing facility it opened in 2021, putting jobs on the chopping block.